Genetec Technology Berhad

KLSE:GENETEC Stock Report

Market Cap: RM 231.9m

Genetec Technology Berhad Management

Management criteria checks 1/4

Genetec Technology Berhad's CEO is Kem Chin, appointed in Oct 1997, has a tenure of 28.58 years. total yearly compensation is MYR4.67M, comprised of 17.6% salary and 82.4% bonuses, including company stock and options. directly owns 9.3% of the company’s shares, worth MYR21.56M. The average tenure of the management team and the board of directors is 0.8 years and 4.4 years respectively.

Key information

Kem Chin

Chief executive officer

RM 4.7m

Total compensation

CEO salary percentage17.62%
CEO tenure28.6yrs
CEO ownership9.3%
Management average tenureless than a year
Board average tenure4.4yrs

Recent management updates

Analysis Article • Sep 22

Genetec Technology Berhad's (KLSE:GENETEC) CEO Will Probably Have Their Compensation Approved By Shareholders

Key Insights Genetec Technology Berhad to hold its Annual General Meeting on 29th of September Salary of RM829.2k is...

Recent updates

Analysis Article • Feb 15

Revenues Working Against Genetec Technology Berhad's (KLSE:GENETEC) Share Price Following 27% Dive

To the annoyance of some shareholders, Genetec Technology Berhad ( KLSE:GENETEC ) shares are down a considerable 27% in...
Analysis Article • Nov 04

Genetec Technology Berhad (KLSE:GENETEC) Might Not Be As Mispriced As It Looks After Plunging 26%

Unfortunately for some shareholders, the Genetec Technology Berhad ( KLSE:GENETEC ) share price has dived 26% in the...
Analysis Article • Oct 15

Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Sep 02

Genetec Technology Berhad (KLSE:GENETEC) Stock's 32% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Unfortunately for some shareholders, the Genetec Technology Berhad ( KLSE:GENETEC ) share price has dived 32% in the...
Analysis Article • Aug 26

We Like These Underlying Return On Capital Trends At Genetec Technology Berhad (KLSE:GENETEC)

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
Analysis Article • Jul 22

Calculating The Intrinsic Value Of Genetec Technology Berhad (KLSE:GENETEC)

Key Insights The projected fair value for Genetec Technology Berhad is RM0.75 based on 2 Stage Free Cash Flow to Equity...
Analysis Article • May 14

Genetec Technology Berhad (KLSE:GENETEC) Shareholders Will Want The ROCE Trajectory To Continue

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
Analysis Article • Mar 09

It's Down 27% But Genetec Technology Berhad (KLSE:GENETEC) Could Be Riskier Than It Looks

The Genetec Technology Berhad ( KLSE:GENETEC ) share price has softened a substantial 27% over the previous 30 days...
Analysis Article • Feb 13

Need To Know: Analysts Are Much More Bullish On Genetec Technology Berhad (KLSE:GENETEC) Revenues

Genetec Technology Berhad ( KLSE:GENETEC ) shareholders will have a reason to smile today, with the analysts making...
Analysis Article • Jan 22

Genetec Technology Berhad (KLSE:GENETEC) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Despite an already strong run, Genetec Technology Berhad ( KLSE:GENETEC ) shares have been powering on, with a gain of...
Analysis Article • Dec 08

Genetec Technology Berhad (KLSE:GENETEC) Shares Fly 25% But Investors Aren't Buying For Growth

Genetec Technology Berhad ( KLSE:GENETEC ) shareholders have had their patience rewarded with a 25% share price jump in...
Analysis Article • Dec 03

Analysts Just Shaved Their Genetec Technology Berhad (KLSE:GENETEC) Forecasts Dramatically

One thing we could say about the analysts on Genetec Technology Berhad ( KLSE:GENETEC ) - they aren't optimistic...
Analysis Article • Nov 28

Here's Why Genetec Technology Berhad (KLSE:GENETEC) Can Manage Its Debt Responsibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Oct 23

Genetec Technology Berhad (KLSE:GENETEC) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Unfortunately for some shareholders, the Genetec Technology Berhad ( KLSE:GENETEC ) share price has dived 25% in the...
Analysis Article • Sep 22

Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article • Aug 27

Genetec Technology Berhad (KLSE:GENETEC) Analysts Are More Bearish Than They Used To Be

The latest analyst coverage could presage a bad day for Genetec Technology Berhad ( KLSE:GENETEC ), with the analysts...
Analysis Article • Aug 19

Not Many Are Piling Into Genetec Technology Berhad (KLSE:GENETEC) Stock Yet As It Plummets 27%

The Genetec Technology Berhad ( KLSE:GENETEC ) share price has fared very poorly over the last month, falling by a...
Analysis Article • Aug 06

Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Feb 26

Genetec Technology Berhad's (KLSE:GENETEC) P/E Still Appears To Be Reasonable

With a price-to-earnings (or "P/E") ratio of 28.4x Genetec Technology Berhad ( KLSE:GENETEC ) may be sending very...
Analysis Article • Jan 15

Slowing Rates Of Return At Genetec Technology Berhad (KLSE:GENETEC) Leave Little Room For Excitement

There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
Analysis Article • Sep 22

Genetec Technology Berhad's (KLSE:GENETEC) CEO Will Probably Have Their Compensation Approved By Shareholders

Key Insights Genetec Technology Berhad to hold its Annual General Meeting on 29th of September Salary of RM829.2k is...
Analysis Article • Feb 08

Does Genetec Technology Berhad (KLSE:GENETEC) Deserve A Spot On Your Watchlist?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article • Dec 28

Genetec Technology Berhad (KLSE:GENETEC) Is Investing Its Capital With Increasing Efficiency

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article • Nov 17

Does Genetec Technology Berhad (KLSE:GENETEC) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Aug 16

Investors Shouldn't Overlook Genetec Technology Berhad's (KLSE:GENETEC) Impressive Returns On Capital

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article • Jul 21

Genetec Technology Berhad (KLSE:GENETEC) Has A Pretty Healthy Balance Sheet

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

CEO Compensation Analysis

How has Kem Chin's remuneration changed compared to Genetec Technology Berhad's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025n/an/a

-RM 154m

Sep 30 2025n/an/a

-RM 78m

Jun 30 2025RM 5mRM 822k

-RM 31m

Jun 30 2024RM 994kRM 1m

RM 69m

Mar 31 2024n/an/a

RM 76m

Dec 31 2023n/an/a

RM 69m

Sep 30 2023n/an/a

RM 59m

Jun 30 2023n/an/a

RM 66m

Mar 31 2023RM 965kRM 829k

RM 50m

Dec 31 2022n/an/a

RM 70m

Sep 30 2022n/an/a

RM 75m

Jun 30 2022n/an/a

RM 67m

Mar 31 2022RM 952kRM 827k

RM 56m

Dec 31 2021n/an/a

RM 37m

Sep 30 2021n/an/a

RM 20m

Jun 30 2021n/an/a

RM 6m

Mar 31 2021RM 947kRM 821k

-RM 4m

Dec 31 2020n/an/a

-RM 6m

Sep 30 2020n/an/a

RM 1m

Jun 30 2020n/an/a

-RM 1m

Mar 31 2020RM 1mRM 840k

-RM 166k

Compensation vs Market: Kem's total compensation ($USD1.18M) is above average for companies of similar size in the MY market ($USD127.13K).

Compensation vs Earnings: Kem's compensation has increased whilst the company is unprofitable.

CEO

Kem Chin (55 yo)

28.6yrs
Tenure
RM 4,666,930
Compensation

Mr. Kem Weng Chin is Chief Executive Officer of Genetec Technology Berhad since August 28, 2025 He served as the Managing Director of Genetec Technology Berhad since October 27, 1997 until August 28, 2025...

Leadership Team

NamePositionTenureCompensationOwnership
Kem Chin
CEO & Executive Director28.6yrsRM 4.67m9.3%
MYR 21.6m
Ewe Sow
Deputy CEO & Executive Directorless than a yearRM 4.20m1.78%
MYR 4.1m
Kon Tan
Chief Financial Officer16.6yrsno data1.82%
MYR 4.2m
Chong Tan
Senior Vice President of Business Developmentless than a yearno datano data
Kean Chua
Senior Vice President of Strategic Operations & Corporate Affairsless than a yearno datano data
Jen Foo
Senior Vice President of Corporate & Operations Financeless than a yearno datano data
Sook Low
Company Secretary15.6yrsno datano data
0.8yrs
Average Tenure
50yo
Average Age

Experienced Management: GENETEC's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Kem Chin
CEO & Executive Directorno dataRM 4.67m9.3%
MYR 21.6m
Ewe Sow
Deputy CEO & Executive Director7.6yrsRM 4.20m1.78%
MYR 4.1m
Phoe Ong
Independent Non-Executive Director5.8yrsRM 120.00k0.11%
MYR 260.4k
Siew Ong
Independent Non-Executive Director2.6yrsRM 72.00kno data
Ting Lik-Hook
Independent Non-Executive Chairman3yrsRM 144.00k0.52%
MYR 1.2m
4.4yrs
Average Tenure
55yo
Average Age

Experienced Board: GENETEC's board of directors are considered experienced (4.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/21 14:27
End of Day Share Price 2026/05/21 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genetec Technology Berhad is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhen Ye KhooCLSA
null nullMercury Securities Sdn. Bhd